Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011–2017: Lessons Learned for Anticancer Drug Development

Detalles Bibliográficos
Autores principales: Faucette, Stephanie, Wagh, Santosh, Trivedi, Ashit, Venkatakrishnan, Karthik, Gupta, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867000/
https://www.ncbi.nlm.nih.gov/pubmed/29266809
http://dx.doi.org/10.1111/cts.12527
_version_ 1783308908750700544
author Faucette, Stephanie
Wagh, Santosh
Trivedi, Ashit
Venkatakrishnan, Karthik
Gupta, Neeraj
author_facet Faucette, Stephanie
Wagh, Santosh
Trivedi, Ashit
Venkatakrishnan, Karthik
Gupta, Neeraj
author_sort Faucette, Stephanie
collection PubMed
description
format Online
Article
Text
id pubmed-5867000
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58670002018-03-28 Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011–2017: Lessons Learned for Anticancer Drug Development Faucette, Stephanie Wagh, Santosh Trivedi, Ashit Venkatakrishnan, Karthik Gupta, Neeraj Clin Transl Sci Reviews John Wiley and Sons Inc. 2017-12-19 2018-03 /pmc/articles/PMC5867000/ /pubmed/29266809 http://dx.doi.org/10.1111/cts.12527 Text en © 2017 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Reviews
Faucette, Stephanie
Wagh, Santosh
Trivedi, Ashit
Venkatakrishnan, Karthik
Gupta, Neeraj
Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011–2017: Lessons Learned for Anticancer Drug Development
title Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011–2017: Lessons Learned for Anticancer Drug Development
title_full Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011–2017: Lessons Learned for Anticancer Drug Development
title_fullStr Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011–2017: Lessons Learned for Anticancer Drug Development
title_full_unstemmed Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011–2017: Lessons Learned for Anticancer Drug Development
title_short Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011–2017: Lessons Learned for Anticancer Drug Development
title_sort reverse translation of us food and drug administration reviews of oncology new molecular entities approved in 2011–2017: lessons learned for anticancer drug development
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867000/
https://www.ncbi.nlm.nih.gov/pubmed/29266809
http://dx.doi.org/10.1111/cts.12527
work_keys_str_mv AT faucettestephanie reversetranslationofusfoodanddrugadministrationreviewsofoncologynewmolecularentitiesapprovedin20112017lessonslearnedforanticancerdrugdevelopment
AT waghsantosh reversetranslationofusfoodanddrugadministrationreviewsofoncologynewmolecularentitiesapprovedin20112017lessonslearnedforanticancerdrugdevelopment
AT trivediashit reversetranslationofusfoodanddrugadministrationreviewsofoncologynewmolecularentitiesapprovedin20112017lessonslearnedforanticancerdrugdevelopment
AT venkatakrishnankarthik reversetranslationofusfoodanddrugadministrationreviewsofoncologynewmolecularentitiesapprovedin20112017lessonslearnedforanticancerdrugdevelopment
AT guptaneeraj reversetranslationofusfoodanddrugadministrationreviewsofoncologynewmolecularentitiesapprovedin20112017lessonslearnedforanticancerdrugdevelopment

Ejemplares similares